● Recruiting

Magnetic Resonance-Guided Focused Ultrasound Bilateral Capsulotomy for the Treatment of Refractory Bipolar Depression

Condition: Treatment-Resistant Depression · Bipolar Depression · Sponsor: Sunnybrook Health Sciences Centre

PhaseNA

Planned participants10

Who can joinAll sexes, 18 Years to 65 Years

Healthy volunteersNo

About this study

The goal of this clinical trial is to evaluate the safety and initial effectiveness of MR-guided focused ultrasound (MRgFUS) bilateral capsulotomy in patients with treatment-resistant bipolar depression (TRBD).

This description comes directly from the study's public registry record.

Talk to the study team

Nir Lipsman, MD, PhD, FRCSC · (416)-480-6954 · Nir.Lipsman@sunnybrook.ca

Anusha Baskaran, PhD · 416-480-6100 · anusha.baskaran@sunnybrook.ca

Always discuss trial participation with your own doctor first.

Locations (1)

Sunnybrook Health Sciences Centre

Toronto, Ontario, Canada

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07108257